DK51481A - Fremgangsmaade til bestemmelse af carcinoembryonisk antigen - Google Patents

Fremgangsmaade til bestemmelse af carcinoembryonisk antigen

Info

Publication number
DK51481A
DK51481A DK51481A DK51481A DK51481A DK 51481 A DK51481 A DK 51481A DK 51481 A DK51481 A DK 51481A DK 51481 A DK51481 A DK 51481A DK 51481 A DK51481 A DK 51481A
Authority
DK
Denmark
Prior art keywords
determining
carcinoembryonic antigen
carcinoembryonic
antigen
determining carcinoembryonic
Prior art date
Application number
DK51481A
Other languages
Danish (da)
English (en)
Inventor
H J Hansen
A D Myl
J P Vandevoorde
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK51481A publication Critical patent/DK51481A/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57473—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving carcinoembryonic antigen, i.e. CEA
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/80—Fluorescent dyes, e.g. rhodamine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK51481A 1980-02-08 1981-02-05 Fremgangsmaade til bestemmelse af carcinoembryonisk antigen DK51481A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/120,017 US4299815A (en) 1980-02-08 1980-02-08 Carcinoembryonic antigen determination

Publications (1)

Publication Number Publication Date
DK51481A true DK51481A (da) 1981-08-09

Family

ID=22387781

Family Applications (1)

Application Number Title Priority Date Filing Date
DK51481A DK51481A (da) 1980-02-08 1981-02-05 Fremgangsmaade til bestemmelse af carcinoembryonisk antigen

Country Status (8)

Country Link
US (1) US4299815A (no)
EP (1) EP0033960A3 (no)
JP (1) JPS56126763A (no)
AU (1) AU6696781A (no)
CA (1) CA1140045A (no)
DK (1) DK51481A (no)
ES (1) ES8205062A1 (no)
NO (1) NO810423L (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU543007B2 (en) * 1980-04-15 1985-03-28 Technicon Instruments Corportion Agglutination immunoassay
US4535058A (en) * 1982-10-01 1985-08-13 Massachusetts Institute Of Technology Characterization of oncogenes and assays based thereon
US6713619B1 (en) 1980-08-29 2004-03-30 Massachusetts Institute Of Technology Oncogenes and methods for their detection
EP0072902B1 (de) * 1981-08-21 1985-04-24 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Verfahren zur Bestimmung von carcinoembryonalem Antigen (CEA) und zur Bestimmung geeignete Antikörperlösung
US4578349A (en) * 1982-04-08 1986-03-25 Abbott Laboratories Immunoassay for carcinoembryonic antigen (CEA)
JPH0811075B2 (ja) * 1982-06-30 1996-02-07 雄治 松岡 単クローン性抗ｃｅａ抗体
US4631254A (en) * 1982-12-06 1986-12-23 Hoffmann-La Roche Inc. Carcinoembryonic antigen determination
IT1174800B (it) * 1983-11-21 1987-07-01 Alberto Bartorelli Metodo per la determinazione di immunoglobuline umane specifiche per gli antigeni dei carcinomi umani e sua utilizzazione nella sierodiognosi di forme primitive tumorali
GB8427006D0 (en) * 1984-10-25 1984-11-28 Iq Bio Ltd Determination of chlamydia trachomatis
US5026653A (en) * 1985-04-02 1991-06-25 Leeco Diagnostic, Inc. Scavenger antibody mixture and its use for immunometric assay
JPH0792454B2 (ja) * 1986-08-04 1995-10-09 栄治 石川 抗原の測定方法
US6013772A (en) * 1986-08-13 2000-01-11 Bayer Corporation Antibody preparations specifically binding to unique determinants of CEA antigens or fragments thereof and use of the antibody preparations in immunoassays
US4900684A (en) * 1987-06-01 1990-02-13 Immunomedics, Inc. CEA immunoassay free of human anti-mouse antibody false positives
US4978632A (en) * 1988-12-15 1990-12-18 Kallestad Diagnostics, Inc. Method of pre-treating samples in peroxidase-catalyzed enzyme assays
DE3939052C2 (de) * 1989-11-25 2003-11-06 Pipelife Rohrsysteme Gmbh Verfahren zur Herstellung eines über Muffenverbindungen mit einem gleichen oder einem anderen Rohr verbindbaren Leitungsrohres aus Kunststoff
US5532135A (en) * 1990-02-02 1996-07-02 Cancer Research Fund Of Contra Costa Solid-phase competitive assay utilizing a fusion protein
JPH07500411A (ja) * 1991-02-05 1995-01-12 ファロク　セィディ 癌胎児性抗原を検出するための簡易検査法
US6949629B2 (en) * 2002-03-13 2005-09-27 Aspenbio, Inc. Methods for purifying selected CEA family member proteins
WO2010151180A1 (en) * 2009-06-26 2010-12-29 Atlas Antibodies Ab Improvement of immunodetectability

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3697638A (en) * 1970-06-01 1972-10-10 Hoffmann La Roche Antigens
US3867363A (en) * 1970-06-01 1975-02-18 Hans John Hansen Carcinoembryonic antigens
US3663684A (en) * 1970-06-01 1972-05-16 Hoffmann La Roche Carcinoembryonic antigen and diagnostic method using radioactive iodine
US4180499A (en) * 1971-01-27 1979-12-25 Hoffmann-La Roche Inc. Carcinoembryonic antigens
US4140753A (en) * 1976-04-30 1979-02-20 Scripps Clinic & Research Foundation Diagnostic method and reagent
US4098876A (en) * 1976-10-26 1978-07-04 Corning Glass Works Reverse sandwich immunoassay
US4180556A (en) * 1977-03-09 1979-12-25 Abbott Laboratories Pretreatment method for carcinoembryonic antigen assay

Also Published As

Publication number Publication date
CA1140045A (en) 1983-01-25
EP0033960A3 (de) 1982-04-14
ES499227A0 (es) 1982-06-01
ES8205062A1 (es) 1982-06-01
JPS56126763A (en) 1981-10-05
US4299815A (en) 1981-11-10
AU6696781A (en) 1981-08-13
EP0033960A2 (de) 1981-08-19
JPS6353510B2 (no) 1988-10-24
NO810423L (no) 1981-08-10

Similar Documents

Publication Publication Date Title
DK51481A (da) Fremgangsmaade til bestemmelse af carcinoembryonisk antigen
IT8121122A0 (it) Metodo di determinazione immunologica.
DK350083A (da) Fremgangsmaade til fremstilling af phenylethanolaminer
DK553281A (da) Fremgangsmaade til paavisning af antistof
DK582883A (da) Fremgangsmaade til fremstilling af modelis
DK560081A (da) Fremgangsmaade til fremstilling af hydrocarboner
DK44181A (da) Fremgangsmaade til fremstilling af humant relaxin
DK479981A (da) Fremgangsmaade til fremstilling af 3-aryl-3-hydroxyphthalimidiner
DK460182A (da) Fremgangsmaade til fremstilling af staphylokinase
DK224681A (da) Fremgangsmaade til fremstilling af diaet-oel
DK316981A (da) Fremgangsmaade til fremstilling af pentapeptider
DK40883A (da) Fremgangsmaade til fremstilling af benzothienylallylaminer
DK424083D0 (da) Fremgangsmade til fremstilling af anthracyclinglycosider
DK168082A (da) Fremgangsmaade til fremstilling af metaboliter
DK501582A (da) Fremgangsmaade til fremstilling af acylcyanider
DK105082A (da) Fremgangsmaade til fremstilling af substituerede trifluormethylphenyl-tetrahydropyridiner
DK548081A (da) Fremgangsmaade til fremstilling af buspiron
DK332481A (da) Fremgangsmaade til terbutylering af hydroxyaromatiske forbindelser
DK378381A (da) Fremgangsmaade til fremstilling af beholdere
DK71681A (da) Fremgangsmaade til fremstilling af piperidinokinazoliner
DK385381A (da) Fremgangsmaade til fremstilling af pyraziner
DK219483D0 (da) Fremgangsmade til fremstilling af anthracyclinglycosider
DK385983A (da) Fremgangsmaade til fremstilling af 1-oxacephamer
DK202983A (da) Fremgangsmaade til fremstilling af l-lysin
DK557483A (da) Fremgangsmaade til bestemmelse af cea

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment